Company: CGABL
Filing Date: 2025-09-17
Form Type: 424B5
Source: 0001193125-25-206326
Chunk: 68

Company: Carlyle Group Inc.
Filing Date: 2025-09-17
Form: 424B5
Chunk 68
---
 of the date they were made or at any other time. We will provide without charge to each person to whom this prospectus supplement is delivered, upon his or her written or oral request, a copy of any or all documents referred to above which have been or may be incorporated by reference into this prospectus supplement, excluding exhibits to those documents unless they are specifically incorporated by reference into those documents. You may request copies of those documents from The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, D.C. 20004-2505. You also may contact us at (202) 729-5626or visit our web site at http://www.carlyle.com for copies of those documents. The Carlyle Group Inc.’s web site and the information contained on its web site are not a part of this prospectus supplement, and you should not rely on any such information in making your decision whether to purchase the notes. S-51

PROSPECTUS Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants, Subscription Rights, Purchase Contracts and Units We and any selling securityholders identified in this prospectus or in supplements to this prospectus may from time to time offer and sell, in one or more series or classes, separately or together, the following securities:

| • |     | common stock; |

| • |     | preferred stock; |

| • |     | depositary shares; |

| • |     | debt securities; |

| • |     | warrants; |

| • |     | subscription rights; |

| • |     | purchase contracts; and |

| • |     | units. |

We will offer our securities in amounts, at prices and on terms to be determined at the time we offer those securities. We will provide the specific terms of these securities in supplements to this prospectus when we offer these securities. The securities may be offered on a delayed or continuous basis directly by us and/or selling securityholders, through agents, underwriters or dealers as designated from time to time, through a combination of these methods or any other method as provided in the applicable prospectus supplement. You should read this prospectus and any applicable prospectus supplement carefully before you invest. Our common stock is listed on the Nasdaq Global Select Market, or Nasdaq, under the symbol “CG.” The last reported sale price of our common stock on the Nasdaq on March 21, 2023 was $31.71 per share. Investing in our securities involves risks.